Bioptik Technology Cash Flow Quality Index
Bioptik Technology cash flow quality index. Bioptik Technology (4161) has a Cash Flow Quality Index of 2.03x as of December 2025. Operating cash flow of NT$53.21 Million exceeds net income of NT$26.24 Million, indicating high earnings quality where cash backs reported profits. See Bioptik Technology (4161) flexibility index to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Bioptik Technology (2018–2025)
Cash flow quality index of Bioptik Technology from 2018 to 2025. Historical Cash Flow Quality Index for Bioptik Technology across 7 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore 4161 operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
Bioptik Technology Cash Flow Quality Index by Year (2018–2025)
Bioptik Technology cash flow quality index by year from 2018 to 2025. Year-by-year earnings quality comparison for Bioptik Technology. For the full cash flow conversion analysis, see 4161 cash flow metrics.
| Year | Quality Index | Operating CF (TWD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 0.84x | NT$59.99 Million | NT$71.19 Million | ▼ -50.4% |
| 2024 | 1.70x | NT$158.82 Million | NT$93.57 Million | ▼ -12.3% |
| 2023 | 1.93x | NT$205.95 Million | NT$106.47 Million | ▲ +120.7% |
| 2022 | 0.88x | NT$55.06 Million | NT$62.81 Million | ▲ +141.8% |
| 2021 | -2.10x | NT$-41.15 Million | NT$19.62 Million | ▼ -126.8% |
| 2019 | 7.81x | NT$41.03 Million | NT$5.25 Million | ▲ +393.0% |
| 2018 | 1.59x | NT$41.83 Million | NT$26.39 Million | — |